MarketCap
Facebook
X
Telegram
Allscripts Healthcare Solutions Balance Sheet 2024-2007 | MDRX
Brief overview of Allscripts Healthcare Solutions's financial position
The balance sheet is assessed across five available annual reports spanning 2020 to 2024.
Assets declined from $2.9 billion to $1.4 billion, or -53.7%. The contraction calls for context such as disposals, restructuring or weaker operations.
Asset growth of -53.7% was close to the -56.2% change in liabilities, leaving the funding profile broadly stable.
Equity funds 59.5% of assets versus 55.3% initially. This creates a conservative balance sheet structure.
Negative net debt of -$217.5 million means cash holdings are larger than debt obligations.
The cash share moved from 16.4% to 21.8%. A higher figure generally provides more room in an adverse scenario.
Retained earnings reached $403.4 million, changing -36.3% over the period. A positive accumulated result supports equity.
Conclusion
Allscripts Healthcare Solutions's financial position is more positive than negative: the funding mix is workable, although the cushion is not unlimited.
Annual Balance Sheet Allscripts Healthcare Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-218 M | - | -414 M | 223 M | -288 M | 786 M | 493 M | 1.41 B | 1.22 B | 508 M | 523 M | 499 M | 338 M | 210 M | 360 M | -7.46 M | - | - |
Long Term Debt |
72.2 M | - | 26.4 M | 350 M | 168 M | 551 M | 648 M | 1.53 B | 1.29 B | 612 M | 549 M | 545 M | 363 M | 323 M | 460 M | 63.7 M | - | - |
Long Term Debt Current |
4.52 M | 3.48 M | 6.61 M | 6.13 M | 22.3 M | 23.1 M | 20.1 M | 27.7 M | 15.2 M | - | - | - | 78.8 M | 44.7 M | 29.4 M | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 317 M | 710 M | 803 M | 2.2 B | 1.89 B | 750 M | 703 M | 784 M | 547 M | 530 M | - | - | - | - |
Total Current Liabilities |
422 M | 446 M | 230 M | 488 M | 935 M | 1.21 B | 798 M | 868 M | 667 M | 513 M | 521 M | 517 M | 553 M | 497 M | 431 M | 164 M | - | - |
Total Liabilities |
548 M | 498 M | 487 M | 951 M | 1.25 B | 1.92 B | 1.6 B | 3.07 B | 2.56 B | 1.26 B | 1.22 B | 1.3 B | 1.1 B | 1.04 B | 1.03 B | 252 M | - | - |
Deferred Revenue |
121 M | 113 M | 90.1 M | 87.9 M | 335 M | 380 M | 467 M | 547 M | 364 M | 316 M | 293 M | 251 M | 291 M | 289 M | 229 M | 86 M | - | - |
Retained Earnings |
403 M | 695 M | 12.5 M | 720 M | 633 M | -49.3 M | 133 M | -338 M | -187 M | -190 M | -188 M | -122 M | -17.5 M | -16.4 M | -90 M | -147 M | - | - |
Total Assets |
1.35 B | 1.57 B | 1.5 B | 2.31 B | 2.92 B | 3.21 B | 3.18 B | 4.23 B | 3.83 B | 2.68 B | 2.51 B | 2.62 B | 2.38 B | 2.52 B | 2.42 B | 953 M | - | - |
Cash and Cash Equivalents |
294 M | 447 M | 447 M | 134 M | 478 M | 130 M | 174 M | 156 M | 96.6 M | 117 M | 53.2 M | 63 M | 104 M | 158 M | 129 M | 71.2 M | 325 K | 1.37 M |
Book Value |
804 M | 1.07 B | 1.02 B | 1.36 B | 1.67 B | 1.29 B | 1.58 B | 1.16 B | 1.27 B | 1.42 B | 1.28 B | 1.32 B | 1.28 B | 1.48 B | 1.38 B | 700 M | - | - |
Total Shareholders Equity |
804 M | 1.07 B | 1.02 B | 1.36 B | 1.61 B | 1.29 B | 1.55 B | 1.12 B | 1.23 B | 1.41 B | 1.28 B | 1.32 B | 1.28 B | 1.48 B | 1.38 B | 700 M | 111 M | 81.2 M |
All numbers in USD currency
Quarterly Balance Sheet Allscripts Healthcare Solutions
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
26.4 M | 200 M | 200 M | 377 M | 350 M | 373 M | 421 M | 169 M | 168 M | 1.03 B | 662 M | 680 M | 551 M | 555 M | 823 M | 766 M | 648 M | 1 B | 983 M | 1.06 B | 907 M | 747 M | 730 M | 713 M | 718 M | 663 M | 633 M | 587 M | 612 M | 642 M | 629 M | 542 M | 539 M | 563 M | 537 M | 530 M | 545 M | 531 M | 533 M | 459 M | 363 M | 387 M | 421 M | 295 M | 323 M | 338 M | 384 M | 414 M | 506 M |
Total Liabilities |
- | 514 M | 518 M | 1.08 B | 1.02 B | 1.07 B | 1.15 B | 1.19 B | 1.25 B | 1.94 B | 1.95 B | 2.01 B | 1.92 B | 1.95 B | 1.92 B | 1.79 B | 1.6 B | 2.93 B | 2.76 B | 2.82 B | 2.64 B | 2.32 B | 2.21 B | 2.21 B | 2.17 B | 2.06 B | 1.99 B | 1.24 B | 1.26 B | 1.28 B | 1.31 B | 1.23 B | 1.18 B | 1.29 B | 1.29 B | 1.33 B | 1.3 B | 1.31 B | 1.31 B | 1.29 B | 1.07 B | 1.11 B | 1.2 B | 1.06 B | 1.03 B | 988 M | 1.04 B | 1.02 B | 1.01 B |
Deferred Revenue |
- | 98.9 M | 84.9 M | 106 M | 121 M | 338 M | 364 M | 380 M | 335 M | 339 M | 366 M | 401 M | 336 M | 373 M | 432 M | 504 M | 467 M | 507 M | 531 M | 540 M | 479 M | 392 M | 389 M | 413 M | 364 M | 371 M | 374 M | 365 M | 316 M | 291 M | 304 M | 322 M | 293 M | 277 M | 281 M | 306 M | 251 M | 304 M | 327 M | 328 M | 256 M | 301 M | 309 M | 318 M | 289 M | 265 M | 277 M | 249 M | 200 M |
Retained Earnings |
- | 753 M | 739 M | 803 M | 768 M | 680 M | 664 M | 642 M | 633 M | -94.7 M | -95.2 M | -87.6 M | -49.3 M | -30.4 M | -24.6 M | 125 M | 133 M | -251 M | -228 M | -319 M | -338 M | -355 M | -337 M | -195 M | -187 M | -190 M | -190 M | -188 M | -190 M | -207 M | -201 M | -198 M | -188 M | -186 M | -160 M | -142 M | -122 M | -101 M | -52 M | -29.1 M | -17.5 M | 6.79 M | -2.58 M | -10.6 M | -16.4 M | -40.5 M | -61.5 M | -77.4 M | -83.8 M |
Total Assets |
- | 1.69 B | 1.71 B | 2.43 B | 2.43 B | 2.48 B | 2.54 B | 2.87 B | 2.92 B | 3.15 B | 3.19 B | 3.25 B | 3.21 B | 3.23 B | 3.24 B | 3.24 B | 3.18 B | 4.52 B | 4.35 B | 4.37 B | 4.23 B | 3.88 B | 3.78 B | 3.8 B | 3.83 B | 3.81 B | 3.71 B | 2.62 B | 2.68 B | 2.67 B | 2.7 B | 2.5 B | 2.46 B | 2.57 B | 2.59 B | 2.63 B | 2.62 B | 2.64 B | 2.68 B | 2.62 B | 2.35 B | 2.41 B | 2.48 B | 2.55 B | 2.5 B | 2.43 B | 2.45 B | 2.45 B | 2.38 B |
Cash and Cash Equivalents |
- | 493 M | 500 M | 82.8 M | 133 M | 214 M | 229 M | 513 M | 531 M | 219 M | 199 M | 204 M | 130 M | 129 M | 139 M | 137 M | 174 M | 112 M | 136 M | 135 M | 119 M | 104 M | 82.7 M | 104 M | 95.6 M | 77.3 M | 90.7 M | 100 M | 117 M | 91.4 M | 76.5 M | 88.5 M | 53.2 M | 37.3 M | 39.2 M | 41.6 M | 63 M | 60.8 M | 72 M | 92.2 M | 104 M | 93.7 M | 120 M | 176 M | 158 M | 84.8 M | 116 M | 145 M | 120 M |
Book Value |
- | 1.18 B | 1.2 B | 1.35 B | 1.41 B | 1.42 B | 1.39 B | 1.68 B | 1.67 B | 1.21 B | 1.24 B | 1.24 B | 1.29 B | 1.28 B | 1.32 B | 1.46 B | 1.58 B | 1.58 B | 1.6 B | 1.55 B | 1.59 B | 1.57 B | 1.58 B | 1.59 B | 1.66 B | 1.75 B | 1.72 B | 1.39 B | 1.42 B | 1.4 B | 1.39 B | 1.28 B | 1.28 B | 1.28 B | 1.3 B | 1.31 B | 1.32 B | 1.33 B | 1.37 B | 1.33 B | 1.28 B | 1.3 B | 1.28 B | 1.49 B | 1.48 B | 1.44 B | 1.41 B | 1.43 B | 1.37 B |
Total Shareholders Equity |
- | 1.18 B | 1.2 B | 1.35 B | 1.41 B | 1.42 B | 1.39 B | 1.68 B | 1.67 B | 1.21 B | 1.24 B | 1.24 B | 1.29 B | 1.28 B | 1.32 B | 1.46 B | 1.55 B | 1.09 B | 1.11 B | 1.07 B | 1.12 B | 1.11 B | 1.12 B | 1.15 B | 1.23 B | 1.33 B | 1.34 B | 1.38 B | 1.41 B | 1.38 B | 1.38 B | 1.28 B | 1.28 B | 1.28 B | 1.3 B | 1.31 B | 1.32 B | 1.33 B | 1.37 B | 1.33 B | 1.28 B | 1.3 B | 1.28 B | 1.49 B | 1.48 B | 1.44 B | 1.41 B | 1.43 B | 1.37 B |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Allscripts Healthcare Solutions, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Health information services
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
- | - | $ 27.9 B |  USA |
 |
Accolade
ACCD
|
- | 0.29 % | $ 206 M | USA |
 |
Change Healthcare
CHNG
|
- | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
- | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | USA |
 |
So-Young International
SY
|
$ 1.84 | 0.55 % | $ 143 M |  China |
 |
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
- | - | $ 102 M | USA |
 |
HealthEquity
HQY
|
$ 100.61 | -0.38 % | $ 8.67 B | USA |
 |
Akerna Corp.
KERN
|
- | - | $ 161 M | USA |
 |
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | USA |
 |
Zhongchao
ZCMD
|
$ 1.13 | -11.72 % | $ 3.86 M | China |
 |
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | USA |
 |
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | USA |
 |
Premier
PINC
|
- | - | $ 2.33 B | USA |
 |
American Well Corporation
AMWL
|
$ 10.75 | -0.83 % | $ 173 M | USA |
 |
R1 RCM
RCM
|
- | - | $ 3.81 B | USA |
 |
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
- | - | $ 7.71 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | USA |
 |
OptimizeRx Corporation
OPRX
|
$ 6.05 | -3.51 % | $ 112 M | USA |
 |
Progyny
PGNY
|
$ 31.13 | -1.14 % | $ 2.65 B | USA |
 |
Phreesia
PHR
|
$ 10.73 | 1.13 % | $ 641 M | USA |
 |
GoodRx Holdings
GDRX
|
$ 3.07 | -3.15 % | $ 1.09 B | USA |
 |
Schrödinger
SDGR
|
$ 15.14 | -1.37 % | $ 1.11 B | USA |
 |
Omnicell
OMCL
|
$ 35.37 | -4.69 % | $ 1.63 B | USA |
 |
Health Catalyst
HCAT
|
$ 2.09 | 0.48 % | $ 146 M | USA |
 |
HealthStream
HSTM
|
$ 28.04 | -0.57 % | $ 842 M | USA |
 |
Evolent Health
EVH
|
$ 3.09 | -2.83 % | $ 353 M | USA |
 |
Teladoc Health
TDOC
|
$ 6.71 | 2.05 % | $ 1.18 B | USA |
 |
10x Genomics
TXG
|
$ 47.27 | -4.37 % | $ 5.9 B | USA |
 |
Veeva Systems
VEEV
|
$ 203.78 | 1.1 % | $ 33.4 B | USA |